JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 3,089 articles

Articles by James Calloway

SoFi Shares Gain Ahead of Critical Q1 Report Amid Accounting Scrutiny
Earnings

SoFi Shares Gain Ahead of Critical Q1 Report Amid Accounting Scrutiny

SoFi Technologies shares climbed 2.1% Friday to $19.43 on heavy volume ahead of its April 29 earnings report. The fintech faces its first major update since short seller Muddy Waters questioned its accounting in March.

SOFI AFRM HOOD LC
Netflix Shares Slide on Subdued Q2 Outlook, Hastings Board Exit
Earnings

Netflix Shares Slide on Subdued Q2 Outlook, Hastings Board Exit

Netflix shares tumbled nearly 10% as a weak Q2 revenue and earnings projection overshadowed strong Q1 results and news of co-founder Reed Hastings' planned board departure.

NFLX
Intel Shares Surge to 24-Year Peak Ahead of Critical Earnings Report
Earnings

Intel Shares Surge to 24-Year Peak Ahead of Critical Earnings Report

Intel's stock surged to a dot-com-era high of $70.32 on Friday, fueled by AI partnerships and a major fab buyback, setting the stage for a pivotal earnings report this week.

INTC GOOGL TSLA AMD NVDA TSM APO
Alphabet's AI Spending Surge Draws Investor Scrutiny Ahead of Earnings
Earnings

Alphabet's AI Spending Surge Draws Investor Scrutiny Ahead of Earnings

Alphabet shares traded near $337 as investors await its April 29 earnings, with attention on a potential capital expenditure surge to $185 billion for 2026 and recent AI chip deals.

GOOGL META MSFT AMZN ASML TSM AVGO BLK SPY QQQ
FDA Peptide Review Sparks Rally for Hims & Hers Health
Regulation

FDA Peptide Review Sparks Rally for Hims & Hers Health

Shares of Hims & Hers Health climbed sharply after regulators signaled a review of peptide restrictions, a development analysts view as a positive shift for the company's growth strategy.

HIMS
Hims & Hers Stock Jumps on FDA's Peptide Policy Review
Regulation

Hims & Hers Stock Jumps on FDA's Peptide Policy Review

Shares of Hims & Hers Health climbed sharply after the U.S. Food and Drug Administration said it will reconsider regulations on certain peptides. The company, which acquired a peptide facility last year, sees this as an opportunity to expand beyond the GLP-1 market.

HIMS
Microsoft Shares Surge on Strong Azure, Copilot Demand Ahead of Q3 Earnings
Earnings

Microsoft Shares Surge on Strong Azure, Copilot Demand Ahead of Q3 Earnings

Microsoft shares gained 4.5% Wednesday following a survey indicating rising enterprise adoption of Azure and Copilot. The company reports fiscal third-quarter results on April 29.

MSFT AMZN GOOGL
Bank of America Q1 Profit Surges 17% on Strong Trading, Investment Banking
Earnings

Bank of America Q1 Profit Surges 17% on Strong Trading, Investment Banking

Bank of America's first-quarter profit rose 17% to $8.6 billion, exceeding analyst forecasts. Revenue increased 7% to $30.3 billion, supported by record equities trading and a rebound in investment banking.

BAC JPM C MS XLF
Morgan Stanley Q1 Results Surge on Trading, Wealth Management Strength
Earnings

Morgan Stanley Q1 Results Surge on Trading, Wealth Management Strength

Morgan Stanley delivered record first-quarter revenue and profit, exceeding analyst forecasts. Strong performance in equities trading and wealth management fueled the results, with shares gaining in premarket trading.

MS JPM C GS XLF SPY
LiveScore Revenue Surges Past £200M Amid UK Tax Hike Concerns
Earnings

LiveScore Revenue Surges Past £200M Amid UK Tax Hike Concerns

LiveScore Group reported a 15.3% revenue rise to £206.3M, with operating loss nearly halved. The results come as the UK hikes online gambling tax to 40%, potentially adding £20-25M to its tax bill.

EWU
Citigroup Q1 Earnings Surge on Strong Trading and Investment Banking
Earnings

Citigroup Q1 Earnings Surge on Strong Trading and Investment Banking

Citigroup reported a 42% surge in first-quarter profit to $5.8 billion, with revenue climbing 14% to $24.6 billion, marking its strongest quarterly performance in ten years.

C JPM WFC GS
J&J Q1 Earnings Surpass Expectations, Lifts 2026 Forecast
Earnings

J&J Q1 Earnings Surpass Expectations, Lifts 2026 Forecast

Johnson & Johnson exceeded Wall Street's first-quarter forecasts, driven by strong performance from Darzalex and Tremfya. The company raised its full-year 2026 sales guidance.

JNJ AMGN BMY ABBV